Chidamide maintenance therapy significantly improves overall and progression-free survival outcomes in patients with T-cell acute lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation, exhibiting an acceptable safety profile, while also highlighting the importance of pre-transplant remission status as a prognostic factor. #Chidamide #TcellLeukemia #AllogeneicTransplant
Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL - Annals of Hematology
